Introducing ▼ REZZAYO® (rezafungin) the first once weekly echinocandin indicated for the treatment of invasive candidiasis in adults.
Introducing ▼REZZAYO® (rezafungin) the first once weekly echinocandin indicated for the treatment of invasive candidiasis in adults.
Professor Tihana Bicanic Professor Oliver Cornely Professor Matteo Bassetti
Launch webinar introducing ▼REZZAYO® (rezafungin) the first once weekly echinocandin indicated for the treatment of invasive candidiasis in adults. Consideration should be given to official guidance on the appropriate use of antifungal agents.1 Speakers Professor Tihana Bicanic, Professor Oliver Cornley and Matteo Bassetti present.
Professor Tihana Bicanic
Reader and Consultant in Infectious diseases at St George's University of London.
Introducing ▼ REZZAYO® (rezafungin) the first once weekly echinocandin indicated for the treatment of invasive candidiasis in adults.
Professor Tihana Bicanic Professor Oliver Cornely Professor Matteo Bassetti
Launch webinar introducing ▼REZZAYO® (rezafungin) the first once weekly echinocandin indicated for the treatment of invasive candidiasis in adults. Consideration should be given to official guidance on the appropriate use of antifungal agents.1 Speakers Professor Tihana Bicanic, Professor Oliver Cornley and Matteo Bassetti present.
Professor Tihana Bicanic
Reader and Consultant in Infectious diseases at St George's University of London.
UK-FLU-2200010 | May 2024
27:15
Launch webinar introducing ▼REZZAYO® (rezafungin) the first once weekly echinocandin indicated for the treatment of invasive candidiasis in adults. Consideration should be given to official guidance on the appropriate use of antifungal agents.1 Speakers Professor Tihana Bicanic, Professor Oliver Cornley and Matteo Bassetti present.
